Determination of the Aneurysm Vulnerability Index by Stimulation and Medical Imaging
ANEUVISM
1 other identifier
interventional
45
1 country
1
Brief Summary
Stroke is the leading cause of disability in France with 130,000 cases per year, 20% of strokes being hemorrhagic, with a majority of intracranial aneurysm rupture (80%). Each year, 6000 meningeal hemorrhages (MHA) caused by cerebral aneurysm rupture are reported in France: 40% of patients die within the first month and 30% are left with severe and permanent disability. Intracranial aneurysms are present in 2 to 6% of the population and only about 0.5% of them will rupture. Given the human and economic costs associated with this disease, systematic medical screening for intracranial aneurysms could be useful. However, the operative risk of endovascular treatment remains non-zero (around 1%) and could be proposed only to a selected population of aneurysms at risk of rupture. The absence of diagnostic criteria for aneurysmal vulnerability does not allow for the moment to consider screening for this disease, which continues to strike without warning a young and active population. Nevertheless, access to brain imaging allows the detection of an increasing number of intracranial aneurysms. The question of preventive treatment then arises and is still a difficult point discussed by neurosurgeons / neurointerventionists based on general epidemiological data difficult to apply to an individual.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2017
CompletedFirst Submitted
Initial submission to the registry
December 27, 2021
CompletedFirst Posted
Study publicly available on registry
January 12, 2022
CompletedJanuary 12, 2022
December 1, 2021
3.5 years
December 27, 2021
January 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Quantify the aneurysmal pulsation in functional MRI
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm or Non ruptured Aneurysm
1 day
Study Arms (2)
Ruptured Cerebral Aneurysm
OTHERQuantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Non Ruptured Cerebral Aneurysm
OTHERQuantify the aneurysmal pulsation in functional MRI on the patient with Non Ruptured Cerebral Aneurysm
Interventions
Quantify the aneurysmal pulsation in functional MRI on the patient with Ruptured Cerebral Aneurysm
Eligibility Criteria
You may qualify if:
- Age limits to \> 18 years
- Collection of the informed consent (patient or legal representant)
- Affiliation or recipient with the mode of social security
- \- Groupe anévrysme rompu
- Patient porteur d'un anévrysme rompu
- \- Groupe anévrysme non rompu
- Patient porteur d'un anévrysme non rompu
You may not qualify if:
- Subject presenting contraindications in MRI (Ferromagnetic foreign bodies, pace-maker …)
- Claustrophobia
- Women pregnant or Breast-feeding
- Patient participating in an other study
- Person with majority age protected by the law (supervision or trusteeship).
- Patient not reading the french language
- Patient or representant for whom it impossible to give accurate informations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
COSTALAT
Montpellier, 34295, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
VINCENT COSTALAT
University Hospital, Montpellier
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 27, 2021
First Posted
January 12, 2022
Study Start
June 1, 2014
Primary Completion
December 1, 2017
Study Completion
December 1, 2017
Last Updated
January 12, 2022
Record last verified: 2021-12